Clarity Pharmaceuticals (ASX: CU6) – Deep Dive Investment Analysis
Date: February 22, 2026 Current Price: ~A$3.45 | Market Cap: ~A$1.33B | Cash: ~A$253M (as of Sept 30, 2025) FY25 Revenue: A$9.5M (R&D incentives, pre-commercial) | Quarterly Burn: ~A$35M | Shares Outstanding: ~385M 52-Week Range: A$1.43 -- A$5.87 | H1 FY26